The Argentine health authority, Anmat, has implemented a nationwide ban on the use, marketing, and distribution of a medication intended for altitude sickness, several children's cosmetics designed for the lips, and a range of hair products used for straightening or treating hair. This move follows inspections that uncovered irregularities, including a lack of sanitary registration for these products or an inability to verify their origin. According to official reports published in the Official Bulletin, the prohibited items either did not appear in Anmat's official databases or were being marketed without compliance with current regulations.

Among the banned items is the medication Puna Cap, marketed in coated tablet form. This decision is part of Anmat's broader efforts to ensure the safety and efficacy of health-related products in Argentina, particularly for vulnerable populations such as children. By preventing the distribution of unapproved products, Anmat aims to uphold public health standards and protect consumers from potential risks associated with these unverified items.

The implications of this ban are significant, as it reflects ongoing regulatory oversight in the Argentine health sector and enhances consumer confidence in the safety of market products. As Anmat continues to monitor the market, such measures highlight the importance of proper registration and compliance for healthcare products, ensuring that only safe and effective options are available to the public. This action not only targets specific products but also aims to foster a culture of accountability among suppliers and manufacturers in the health and cosmetic industries.